methamphetamine has been researched along with kynurenic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Witkin, JM | 1 |
| Bland, LR; Layer, RT; Skolnick, P | 1 |
| Budzynska, B; Kaszubska, K; Kotlinska, JH; Lemieszek, MK; Marciniak, S; Marszalek-Grabska, M; Rzeski, W; Turski, WA; Winiarczyk, S; Zakrocka, I | 1 |
3 other study(ies) available for methamphetamine and kynurenic acid
| Article | Year |
|---|---|
Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists.
Topics: Amino Acids; Animals; Cocaine; Excitatory Amino Acid Antagonists; Glutamic Acid; Kynurenic Acid; Male; Methamphetamine; Mice; Motor Activity; Pyrrolidinones; Quinoxalines | 1993 |
MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Amino Acids, Cyclic; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Kynurenic Acid; Male; Methamphetamine; Mice; Mice, Inbred Strains; Receptors, Glycine; Strychnine; Substantia Nigra | 1993 |
Binge-like mephedrone treatment induces memory impairment concomitant with brain kynurenic acid reduction in mice.
Topics: Adolescent; Animals; Humans; Kynurenic Acid; Kynurenine; Methamphetamine; Mice; Transaminases; Tryptophan | 2022 |